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Abstract
Background: Doublecortin and calcium/calmodulin-dependent protein kinase-like-1 (DCAMKL1) is a candidate 
marker for progenitor cells in the gastrointestinal mucosa. Lineage cells in the gastric mucosa are derived from 
progenitor cells, but this process can be altered after injury. Therefore, we explored DCAMKL1 expression under 
pathological conditions.
Methods: An immunohistochemical analysis was performed in rat stomach with acute superficial injury, chronic ulcer, 
intestinal metaplasia and dysplasia.
Results: DCAMKL1 was exclusively expressed in immature quiescent cells in the isthmus of normal fundic glands, 
where putative progenitor cells are thought to reside. DCAMKL1-positive cells and proliferating cells shed into the 
lumen after superficial injury and re-appeared during the regenerative process, mainly in the superficial mucosa. In the 
marginal mucosa around the active ulcer, parietal and chief cells diminished, foveolar hyperplasia was evident, and 
trefoil factor family 2 (TFF2)/spasmolytic polypeptide-expressing metaplasia (SPEM) emerged at the gland base. 
DCAMKL1 cells re-emerged in the deep mucosa juxtaposed with SPEM and proliferating cells. In the healing ulcer, the 
TFF2 cell population expanded and seemed to redifferentiate to chief cells, while proliferating cells and DCAMKL1 cells 
appeared above and below the TFF2 cells to promote healing. SPEM appeared and PCNA cells increased in the 
intestinalized mucosa, and DCAMKL1 was expressed in the proximity of the PCNA cells in the deep mucosa. DCAMKL1, 
PCNA and TFF2 were expressed in different dysplastic cells lining dilated glands near SPEM.
Conclusion: The ultrastructural appearance of DCAMKL1-positive cells and the expression patterns of DCAMKL1 in 
normal and pathological states indicate that the cells belong to a progenitor cell population. DCAMKL1 expression is 
closely associated with TFF2/SPEM cells after injury. DCAMKL1 cells repopulate close to proliferating, hyperplastic, 
metaplastic and dysplastic cells, and the progenitor zone shifts according to the pathological circumstances.
Background
The mouse and human gastric unit shows monoclonal
conversion, indicating the presence of multipotent stem
cells[1,2]. Electron microscopic autoradiography in
mouse have implied that granule-free cells in the isthmus
act as multipotent stem cells[3]. The differentiation and
migration processes of cell lineages can be altered by
injury. The progenitor cell zone in the isthmus is easily
damaged by intraluminal ethanol, non-steroidal anti-
inflammatory drugs or Helicobacter pylori (H. pylori).
Chronic inflammation of the stomach can lead to atrophy
and specialized cell loss as tangible effects of tissue-spe-
cific progenitor cell injury or loss. However, the behavior
of progenitor cells after acute or chronic mucosal damage
and the mechanism of restoration of these cells during
mucosal regeneration are not well understood.
The progenitor cell population is important in mainte-
nance and regeneration of the gastric epithelium, but
long-lived progenitor cells are at risk of accumulating
mutations that lead to cancer[4]. Neoplasia can follow
cellular metaplasia due to chronic inflammation and
repair. However, precise analysis of the role and alteration
of progenitor cells in the sequence of gastritis-metapla-
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Page 2 of 14sia-dysplasia-cancer has not been performed, mainly due
to the lack of discrete progenitor cell markers in the
stomach.
Musashi-1, a marker of progenitor cells in the mouse
small intestine, is not expressed in putative progenitor
cells, but is found in parietal cells in the rat fundic isth-
mus[5]. The villin-1 promoter/enhancer fragment is a
marker of possible gastric progenitor cells in the isthmus
of the pyloric glands[6]. A lineage study indicated that the
intestinal progenitor cell marker Lgr5 is expressed at the
base of prospective fundic and pyloric glands in the neo-
natal stomach, whereas expression in adult was predomi-
nantly restricted to the base of the pyloric glands[7].
Thus, there are no definite markers for progenitors in
adult fundic glands.
DCAMKL1 is one of the products of Gene Ontogeny-
enriched transcripts found in comparison with mouse
gastric and small intestinal progenitor datasets[8]. Immu-
nohistochemical analysis using a DCAMKL1 antibody
revealed single cell staining in intestinal crypt sections at
or near position 4 and in gastric isthmus cells[8]. After
the first report, specific localization of DCAMKL1-
expressing cells in a stem cell niche was shown in the
small intestine of mice[9,10] and in the colon of mice and
humans[11,12], whereas DCAMKL1 was coexpressed
with Musashi-1 in parietal cells in the stomach of
mice[13].
The first aim of this study was to determine whether
DCAMKL1 is a marker for progenitor cells in the rat
stomach. The second aim was to elucidate the temporal
and spatial patterns of appearance of cells specifically
expressing DCAMKL1 under several gastric pathological
conditions.
Methods
Animal Preparation
All animal protocols were approved by the Keio Univer-
sity Animal Research Committee. Male Wistar rats
weighing about 200 g were fasted for 24 hours with free
access to water. To produce acute superficial injury in the
fundic mucosa, absolute ethanol (1 ml) was instilled into
the stomach by gastric intubation. To produce chronic
deep ulcers, 20% acetic acid (50 μl) was injected into the
fundic submucosa of the anterior wall using a microsy-
ringe. The rats were euthanized 3 days and 1, 2 and 3
weeks after the acetic acid injection.
The method for inducing intestinal metaplasia in the
rat gastric mucosa has been described elsewhere[14,15].
Briefly, rats received two X-ray doses of 10 Gy each and
were euthanized 6 months after irradiation. The method
for inducing dysplasia in the rat gastric mucosa has also
been described elsewhere[14]. Briefly, 50 μg/ml of N-
methyl-N'-nitro-N-nitrosoguanidine (MNNG) (Aldrich
Chemical Co., Milwaukee, WI) was given to rats ad libi-
tum for 4 months.
Antibodies
Rabbit anti-DCAMKL1 immunoglobulin (Ig)G (Abcam,
Cambridge, UK; final dilution 1:100), mouse anti-prolif-
erating cell nuclear antigen (PCNA) IgG (DAKO, Carpin-
teria, CA; ready to use), rabbit anti-PCNA IgG (Abcam;
1:200), mouse anti-H+/K+-adenosine triphosphatase
(ATPase) α subunit IgG (Research Diagnostics Inc. Flan-
ders, NJ; 1:200), sheep anti-pepsinogen II IgG (United
States Biological, Swampscott, MA; 1:100), mouse anti-
MUC6 IgM (Kanto Kagaku, Tokyo; 1:100), mouse anti-
MUC5AC IgG (Abcam; 1:100), mouse anti-TFF2 IgM
(Abcam; 1:200), guinea pig anti-histidine decarboxylase
(HDC) IgG (ARP, Belmont, MA; 1:100), goat anti-ghrelin
IgG (Santa Cruz Biotechnology, Santa Cruz, CA; 1:100),
and mouse anti-somatostatin IgG (Biomeda, Foster City,
CA; 1:25) were used as primary antibodies.
Histological Analysis
The stomach tissue was fixed in 10% neutral-buffered for-
malin overnight, and then embedded in paraffin and sec-
tioned (4 μm). The sections were stained with
hematoxylin and eosin (H&E) using standard techniques.
Periodic acid-Schiff (PAS)-Alcian Blue staining was per-
formed to detect mucous cell lineages.
For immunohistochemical analysis, paraffin-embedded
sections were deparaffinized and pretreated with an
appropriate retrieval procedure for each antigen. Sections
were incubated in 0.3% H2O2 in methanol for 10 minutes
to inactivate endogenous peroxidase and then washed
with phosphate-buffered saline (PBS) containing 0.1%
Tween 20 (PBST). After incubation with blocking solu-
tion (Block Ace, Dainippon Seiyaku, Tokyo, Japan) for 10
minutes, the sections were incubated with a primary anti-
body for 1 hour at room temperature. Thereafter, each
step was followed by washing 3 times with PBST for 3
minutes. The sections were incubated with HP-conju-
gated IgG or IgM for 40 minutes. The labeled cells were
colored brown with 3,3'-diaminobenzidine hydrochloride
(DAB) using a DAB reagent set (DAKO), and then coun-
terstained with Mayer's hematoxylin.
For double-color immunostaining, an indirect immu-
noalkaline phosphatase method was used following the
indirect immunoperoxidase procedure described above.
After reaction with DAB, the sections were incubated
with a second primary antibody for 1 hour, followed by
incubation with ALP-conjugated IgG or IgM for 40 min-
utes. The labeled cells were stained blue with an ALP sub-
strate kit III (Vector Blue, Vector Laboratories,
Burlingame, CA).
For antigen retrieval of pepsinogen II and MUC6, pro-
teinase K (DAKO) was applied topically to the deparaf-
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PCNA (mouse IgG), the sections were heated in distilled
water in an autoclave for 10 minutes. For antigen retrieval
of MUC5AC, the sections were heated in citrate buffer in
an autoclave for 10 minutes. No antigen retrieval proce-
dure was used for DCAMKL1, H+/K+-ATPase, PCNA
(rabbit IgG), TFF2, HDC, ghrelin or somatostatin stain-
ing.
Scoring of DCAMKL1 Cells and PCNA Cells
Sections that underwent double-color immunostaining
using DCAMKL1 and PCNA were analyzed to determine
the number of immunostained cells. Sections were used
from 5 rats, and 10 well-oriented gastric units were ana-
lyzed in each section.
Electron Microscopy
Pre-embedding immunoperoxidase electron microscopy
was carried out as follows. Small pieces of fresh speci-
mens from the gastric corpus of untreated rats were fixed
in 4% paraformaldehyde for 24 hours, followed by fixa-
tion in 0.1% glutaraldehyde and 4% paraformaldehyde for
1 hour. Cryostat sections (6 μm) were prepared and incu-
bated with anti-DCAMKL1 antibody for 48 hours, fol-
lowed by incubation with HP-conjugated anti-rabbit IgG
for 24 hours. The sections were then fixed with 0.5% glu-
taraldehyde for 5 minutes, reacted with DAB, post-fixed
with 2% osmium tetroxide, dehydrated through a graded
ethanol series, and embedded in epoxy resin. Ultrathin
sections were cut with an ultramicrotome and stained in
uranyl acetate solution and lead citrate solution. The
specimens were examined using a transmission electron
microscope (JEM-1200EX, JEOL, Tokyo, Japan).
Results
Normal Fundic Gland
DCAMKL1-expressing cells were distributed in the
upper third of normal fundic glands, in a region referred
to as the isthmus (Figure 1A). In electron microscopy,
DCAMKL1-cells were also found in the isthmus (Figure
1B, a). The DCAMKL1 cell was smaller than the parietal
cell, which was rich in mitochondria, and lacked the
secretory granules seen in the endocrine cell (Figure 1B,
b). DCAMKL1 immunoreactivity was found diffusely in
the cytoplasm, giving a high nucleocytoplasmic ratio
(Figure 1B, c). DCAMKL1 cells were present in epithelial
cell linings, since the cells had desmosomes in the junc-
tion with adjacent epithelial cells (Figure 1B, d). The
DCAMKL1 cells had an immature appearance with few
mitochondria, vesicles or secretory granules (Figure 1B, c
and 1B, d).
We next compared the distribution of DCAMKL1 cells
with those of known epithelial cell lineages. DCAMKL1
cells were intermingled with proliferating cells labeled by
Figure 1 Distribution and ultrastructure of DCAMKL1-expressing 
cells in normal rat stomach. (A) A light micrograph, showing location 
of DCAMKL1 cells in the fundic mucosa. Scale: 100 μm. The inset shows 
a magnified view of the outlined area in A. Scale: 10 μm. (B) Transmis-
sion electron micrographs. (a, c) Ultrathin sections without counter-
staining. (b, d) Ultrathin sections with counterstaining. (a) DCAMKL1 
cells in the fundic gland. Scale: 2 μm, magnification ×5600. (b) The 
DCAMKL1 cell (D) was smaller than the parietal cell (P), which was rich 
in mitochondria, and lacked the secretory granules seen in the endo-
crine cell (E). Scale: 2 μm, magnification ×7000. (c) DCAMKL1 staining 
was predominantly cytoplasmic. Scale: 1 μm, magnification ×14400. 
(d) Arrowheads indicate desmosomes. The white arrow shows 
DCAMKL1 immunoreactivity. Scale: 2 μm, magnification ×8400.
Kikuchi et al. BMC Gastroenterology 2010, 10:65
http://www.biomedcentral.com/1471-230X/10/65
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contained PCNA. DCAMKL1 cells resided below foveo-
lar cells (stained with Alcian Blue, Figure 2b) and above
mucous neck cells (stained with MUC6 and TFF2, Figure
2c, d). Parietal cells and chief cells in the isthmus were
adjacent to DCAMKL1 cells, but DCAMKL1 cells did not
coexpress H+/K+-ATPase or pepsinogen (Figure 2e, f).
DCAMKL1 cells were also discrete from endocrine cell
lineages. The DCAMKL1 cell population was distant
from enterochromaffin-like cells, which were principally
distributed in the fundic base (Figure 2g). A majority of
A-like cells resided in the fundic base with some distrib-
uted in the isthmus but distinct from DCAMKL1 cells
(Figure 2h), and D cells clearly differed from DCAMKL1
cells (Figure 2i).
Acute Superficial Mucosal Injury and Rapid Renewal
Histological analysis of the process of mucosal injury and
repair after ethanol administration using H&E staining
and double-color DCAMKL1 and PCNA immunostain-
ing is shown in Figure 3. Immediately after ethanol treat-
ment, DCAMKL1 cells and PCNA cells detached from
the gland and shed into the lumen with foveolar cells
(Figure 3Aa and 3Ba). DCAMKL1 cells and PCNA cells
had almost disappeared in the damaged mucosa 1 hour
after ethanol treatment (Figure 3Ab and 3Bb).
DCAMKL1 cells then reappeared after 6 hours, and some
were present near the mucosal surface (Figure 3Ac and
3Bc). PCNA cells increased at 24 hours after ethanol (Fig-
ure 3Ad and 3Bd), while several DCAMKL1 cells and
PCNA cells were present at the mucosal surface (Figure
Figure 2 Double-color immunostaining showing localization of DCAMKL1-expressing cells and epithelial cell lineages comprising prolif-
erating cells with PCNA-labeled nuclei (a), Alcian Blue-stained foveolar cells (b), MUC6-stained mucous neck cells (c), TFF2-stained mucous 
neck cells (d), H+/K+-ATPase-stained parietal cells (e), pepsinogen II-stained chief cells (f), HDC-stained enterochromaffin-like cells (g), 
ghrelin-stained A-like cells (h), and somatostatin-stained D cells (i). Scales: 100 μm. The inset in (e) shows a magnified view of the outlined area. 
Note that the DCAMKL1 cells were distinct from the parietal cells.
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Figure 3 Immunohistochemical analysis of superficial mucosal injury after ethanol treatment. (A) Double-color immunostaining for DCAMKL1 
cells and PCNA cells. Gastric sections taken at 5 minutes (a), 1 hour (b), 6 hours (c), 24 hours (d, e) and 96 hours (f) after ethanol treatment. (B) H&E-
stained sections, showing the time course of gastric mucosal damage and repair after ethanol administration. (a-f) Serial sections of the respective 
sections in A. Scales: 100 μm.
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PCNA cells had the morphologic appearance of
untreated fundic mucosa after 96 h (Figure 3Af and 3Bf).
Time courses of changes in the numbers of DCAMKL1
and PCNA cells are shown in Figure 4. The number of
DCAMKL1 cells changed almost concomitantly with that
of PCNA cells, but recruitment of DCAMKL1 cells began
at 6 hours after ethanol treatment, prior to recruitment of
PCNA cells.
Chronic Ulcer
Deep ulcers involving whole mucosal layers and penetrat-
ing the muscularis mucosa were produced 3 days after
treatment with acetic acid. Most ulcers healed after 2
weeks of treatment and some recurred after 3 weeks. A
histopathological analysis of mucosal regeneration was
performed using tissues taken at 1 to 3 weeks after treat-
ment. Cystically dilated glands were prominent in the
regenerative mucosa of the ulcer margin around the cra-
ter of an active ulcer (Figure 5a, b). These glands were
lined with cells expressing MUC5AC, a marker of foveo-
lar cells (Figure 5c). In addition, TFF2, a marker of
mucous neck cells in untreated rats, displayed intense
staining at the base of regenerative fundic glands (Figure
5d), similar to that for TFF2 staining of deep antral gland
cells and consistent with the emergence of a SPEM cell
phenotype[16,17]. In contrast, expression of MUC6,
another marker of mucous neck cells in untreated rats,
deteriorated in the regenerative mucosa and only weak
MUC6 staining was observed in cells at the gland base
(Figure 5e). Chief cells also diminished in the ulcer mar-
gin and cells weakly stained with pepsinogen were visual-
ized only at the gland base (Figure 5f). Thus, there was
overlap in expression of TFF2, MUC6 and pepsinogen in
cells at the base (Figure 5, d-f). Parietal cells were absent
in the tissue of the marginal mucosa of the active ulcer
(Figure 5g). PCNA cells increased in the glands and mes-
enchyma of the ulcer margin and a marked increase in
these cells was noted at the gland base (Figure 5h).
We then explored DCAMKL1 expression in the mar-
ginal mucosa of the active ulcer. Dispersed DCAMKL1-
expressing cells were present close to MUC5AC cell lin-
ings (Figure 5i) and juxtaposed with SPEM cells (Figure
5j). PCNA cells were also distributed in the vicinity of
SPEM cells and some SPEM cells coexpressed PCNA
(Figure 5k), implying that the SPEM lineage is multiply-
ing and proliferative. DCAMKL1 cells were intermingled
with PCNA cells at the base of the gland, but did not
coexpress PCNA (Figure 5l). This indicates that
DCAMKL1 cells are maintained in a quiescent state. The
progenitor zone of PCNA cells and DCAMKL1 cells was
displaced from the isthmus in the normal gland to the
base in the margin of the active ulcer.
In the healing stage, the ulcer size reduced and epithe-
lial cells were restored (Figure 6a). In the healing ulcer, a
gradient of epithelial regeneration was present from the
ulcer edge to the regenerated glands distant from the
ulcer (Figure 6b). In the regenerative mucosa of the heal-
ing ulcer, mucous-like cells markedly increased. These
cells were localized at the base in the ulcer margin and
expanded to the necks of glands as healing proceeded.
MUC5AC cells decreased in the neck and was present
mainly in the foveolae (Figure 6c), similar to the location
in the normal fundic mucosa. The expanding mucous-
like cells in the healing ulcer were partly stained by
MUC5AC, but predominantly stained with TFF2 (Figure
6d). MUC6 was expressed in cells at the gland base but
not in those in the neck (Figure 6e), whereas pepsinogen
was expressed in cells in the neck (Figure 6f). Parietal
Figure 4 Time courses of the numbers of DCAMKL1 cells (A) and PCNA cells (B) in a gland after ethanol administration. Each bar represents 
the mean ± SE of results from 5 rats. The Y-axis shows the number of cells per gland and the X-axis shows the time after ethanol administration.
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Figure 5 Patterns of epithelial cells in the marginal mucosa of an active ulcer. (a) An H&E-stained section taken at 1 week after acetic acid treat-
ment, showing a crater of granulation tissue and marginal tissue surrounding the crater. Scale: 1000 μm. (b) A magnified view of the ulcer margin 
mucosa outlined in (a). Scale: 100 μm. (c-h) Serial sections of (b) stained with MUC5AC (c), TFF2 (d), MUC6 (e), pepsinogen II (f), H+/K+-ATPase (g), and 
PCNA (h). (i-k) Double-color immunostaining for DCAMKL1 with MUC5AC (i), DCAMKL1 with TFF2 (j), and PCNA with TFF2 (k). Scales: 100 μm. (l) Dou-
ble-color immunostaining for DCAMKL1 with PCNA. Scale: 10 μm. The inset in (h-k) shows a magnified view of the outlined area.
Kikuchi et al. BMC Gastroenterology 2010, 10:65
http://www.biomedcentral.com/1471-230X/10/65
Page 8 of 14cells, which had vanished in the active ulcer, reappeared
above and below the TFF2 cell population in the mucosa
of the healing ulcer (Figure 6g). In the normal mucosa,
parietal cells are derived from progenitor cells in the isth-
mus, mature therein, and then take several days to
migrate down to the base[18], whereas in the healing
ulcer, parietal cells repopulated the neck and base of the
gland simultaneously. PCNA was expressed strongly just
above TFF2 cells near the ulcer, indicating enhanced
amplification of the epithelial cells in this region (Figure
6h). Some PCNA cells were also distributed below the
TFF2 cells. DCAMKL1 cells reappeared above and juxta-
posed with the lower half of the TFF2 cell population
(Figure 6i). This dual distribution profile of the progeni-
tor zone may contribute to promotion of rapid and effi-
cient mucosal regeneration.
Intestinal Metaplasia and Dysplasia
In irradiated rats, intestinal metaplasia containing goblet
cells identified by PAS-Alcian Blue staining formed in the
fundic gland (Figure 7a). Cells expressing DCAMKL1
were found below foveolar cells in the luminal compart-
ment of the mucosa, as well as in the deep mucosa (Figure
7b, c). PCNA cells increased markedly in the intestinal-
ized mucosa and DCAMKL1 cells in the luminal com-
partment were distal to the PCNA cells (Figure 7c).
TFF2-expressing cells, consistent with SPEM, emerged at
Figure 6 Patterns of epithelial cells and DCAMKL1 cells in the regenerative mucosa of a healing ulcer. (a) An H&E-stained section taken at 2 
weeks after acetic acid treatment, showing the regenerative tissue of the healing ulcer. Scale: 1000 μm. (b) A magnified view of the regenerative mu-
cosa outlined in (a). A gradient of epithelial regeneration from the ulcer edge (right side) to the regenerated mucosa distant from the ulcer (left side) 
was identified. Scale: 100 μm. (c-h) Serial sections of (b), stained with MUC5AC (c), TFF2 (d), MUC6 (e), pepsinogen II (f), H+/K+-ATPase (g), and PCNA 
(h). (i) Double-color immunostaining for DCAMKL1 and TFF2 in a serial section of (b).
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Page 9 of 14the base of the intestinalized mucosa (Figure 7d). PCNA
cells were found proximal to DCAMKL1 cells deep in the
intestinalized epithelial lining, with a similar distribution
pattern to that in the small intestinal crypt (Figure 7e, f).
In rats treated with MNNG, cystic dilation of glands
with dysplasia was elicited in the mucosa and submucosa
(Figure 8a). SPEM evolved and expanded near the dilated
glands and segmental expression of TFF2 was found in
cells lining the glands (Figure 8b). DCAMKL1 was
sparsely expressed in these glands (Figure 8c). TFF2 and
DCAMKL1 were expressed in different cells in the
dilated glands (Figure 8d, 8e), and PCNA was also
expressed in cells other than DCAMKL1 cells, indicating
the proliferative nature of the glands (Figure 8f).
Discussion
The study showed that DCAMKL1-expressing cells are
exclusively present in the isthmus of the rat fundic gland,
in which multipotent progenitor cells are thought to
reside[1,3]. We demonstrated that DCAMKL1 cells are
discrete from differentiated epithelial cells, including
endocrine cell lineages. Furthermore, immunoelectron
microscopy showed that DCAMKL1 was expressed in
immature epithelial cells with few organelles, which cor-
respond to the granule-free cells previously proposed as
presumptive progenitor cells in the gastric isthmus[3].
DCAMKL1 is coexpressed with Musashi-1 in parietal
cells in the mouse stomach[13], whereas this study dem-
onstrated that DCAMKL1 cells were distinct from pari-
etal cells, which express Musashi-1 in the rat stomach[5].
Sequential changes in cellular loss and recovery of the
gastric gland after superficial mucosal injury with ethanol
are summarized in Figure 9. The time courses of changes
in the numbers of DCAMKL1 and PCNA cells 6 to 96
hours after ethanol treatment in rat are consistent with
those in mouse[13]. In addition, we analyzed earlier
changes in these cell types. DCAMKL1 cells and PCNA
cells desquamated with foveolar cells immediately after
ethanol treatment. A denuded mucosal surface after etha-
nol exposure is re-epithelialized in 1 to 2 hours by rapidly
migrating foveolar cells from nearby uninjured epithe-
lium[19]. Since this early restitution is not based on cellu-
lar proliferation but on migration, mobilization of
progenitor cells is not required. After a latent period of
approximately 8 hours, a burst of proliferative activity
occurred until 24 hours to restore the foveolae to their
original length[20]. This time course of epithelial prolifer-
ation after ethanol exposure is similar to that observed in
the present study.
A recent report has shown that PCNA-positive prolif-
erating cells contain prefoveolar cells[21]. The increased
number of proliferating cells are probably derived from
Figure 7 DCAMKL1 expression in the intestinalized mucosa. (a) PAS-Alcian Blue staining showing the mucosa with intestinal metaplasia contain-
ing goblet cells. Scale: 100 μm. (b-d) Serial sections of (a), stained with DCAMKL1 (b), DCAMKL1 and PCNA (c), and TFF2 (d). (e, f) Magnified views of 
the areas outlined in (b) and (c), respectively. Scales: 10 μm.
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ulation after injury is obscure. In this study, DCAMKL1
cells were recruited prior to restoration of proliferating
cells, and the number and distribution of DCAMKL1
cells changed almost concomitantly with those of prolif-
erating cells after 24 hours. This finding implies that
DCAMKL1-expressing cells are progenitor cells that give
rise to proliferating cells. Several DCAMKL1 cells and
PCNA cells were present at the mucosal surface during
the early regenerative period. Transient displacement of
the progenitor zone toward the surface may help to facili-
tate rapid and preferential restoration of foveolar cells,
which is the lineage that is most damaged and lost in
superficial mucosal injury. Since the recruited
DCAMKL1 cells reappeared within a day after the indige-
nous cells were lost, the repopulating DCAMKL1 cells in
the injured mucosa may migrate from non-injured glands
or recruit from progeny of a multipotent stem cell lineage
that undergoes continuous expansion or extinction in the
niche[9,22].
The processes of mucosal reconstruction and progeni-
tor cell repopulation in a chronic deep ulcer differed
clearly from those in acute superficial injury (Figure 10).
Differentiated cell lineages are maintained after acute
superficial injury, whereas orderly differentiation of
mucosal cell lineages in the active ulcer was perturbed
and inherent cell lineages were replaced by newly devel-
oped mucous cell lineages. Parietal and chief cells were
lost, foveolar hyperplasia was evident, and SPEM
emerged in the regenerating epithelium surrounding the
active ulcer. These findings mimic pathological changes
in various experimental models induced by acute or
chronic oxyntic atrophy[16,17,23,24]. In the ulcer margin,
MUC6 and pepsinogen seem to be coexpressed with
TFF2 at the gland base. This finding supports the hypoth-
esis that chief cells transdifferentiate to SPEM[17,25], and
that the process of redifferentiation from mucous neck
cells to chief cells is modified in an active ulcer. An alter-
native explanation, which is more likely based on the
present results, is that SPEM is derived from progenitor
cells and redifferentiates to chief cells. The finding that
SPEM is associated with increased proliferation supports
this proposal[16,24].
Chronic mucosal ulceration in the gastrointestinal tract
initiates a healing process from the mucosal base at the
ulcer edge, and can induce novel cell lineages corre-
sponding to SPEM[26]. These appear to be derived from
multipotent stem cells in the crypt of the small intestine
and colon, whereas SPEM and proliferating cells at the
base of the margin of the gastric ulcer is distant from the
normal progenitor zone in the isthmus. The chronic ulcer
model in this study developed several weeks after treat-
Figure 8 DCAMKL1 expression in the dilated glands with dysplasia. (a) An H&E-stained section, showing cystic dilation of glands. (b) Expansion 
of SPEM. Arrows indicate segmental expression of TFF2 in the dilated glands. (c) Expression of DCAMKL1 in the dilated gland. (d-f) Serial sections of 
the dilated gland for TFF2 (d), DCAMKL1 (e) and DCAMKL1 with PCNA (f). Scales: 100 μm.
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stem cells unlikely because engraftment of these cells as
gastric epithelial cells occurs in mice after sustained H.
felis infection over more than 1 year, but not in mice with
a gastric ulcer induced by acetic acid[27]. The presence of
a second progenitor population, cryptic progenitor cells
in the stomach, has been predicted for many years[16,24],
but has yet to be identified. In this study, putative progen-
itor DCAMKL1 cells were found in the vicinity of two
mucous cell lineages, foveolar cells and SPEM cells, in
hyperplasia at the ulcer margin. DCAMKL1 cells juxta-
posed with SPEM are compatible with the cryptic pro-
genitor cells. The intestinal progenitor cell marker Lgr5 is
present at the base of glands and not in the isthmus[7],
and that a progenitor cell population increased markedly
during inflammation[6]. We hypothesize that
DCAMKL1-expressing cells at the base of the gastric
gland are the second-line progenitor population, which is
masked under physiological conditions. These dormant
progenitors may be activated by inflammatory cytokines
during ulcer formation, and may play a pivotal role in ini-
tiating the healing process.
DCAMKL1 cells and PCNA cells were present close to
TFF2/SPEM cells in the ulcer margin. TFF2 has a healing
function in the stomach[28], but the mechanism is not
fully understood. The function of TFF2, which is protease
resistant and produces mucus/TFF complexes of high vis-
cosity, might be to protect the progenitor zone [29]. Dur-
ing ulcer healing, the TFF2 cell population expanded
from the base to the neck of glands. Unlike mucous neck
cells in the normal mucosa, TFF2 cells in the healing ulcer
coexpressed MUC5AC (but little MUC6) in the neck and
also coexpressed pepsinogen. This suggests that SPEM
cells redifferentiate to chief cells in the process of ulcer
healing.
Alterations of mucosal cell lineages in intestinal meta-
plasia are illustrated in Figure 11A. Intestinal metaplasia
with goblet cells was induced by irradiation in the fundic
mucosa, whereas SPEM developed at the base. Many cells
in the intestinalized mucosa showed proliferation, and
the marked proliferation of these cells is coincident with
that in human atrophic gastritis[30]. In the non-treated
rat, proliferating cells were present in the proximity of
DCAMKL1 cells in the isthmus, whereas in the irradiated
rat, the proliferative zone shifted downward and was sep-
arate from the DCMKL1 cell population in the luminal
compartment. On the other hand, PCNA cells were
found in the proximity of DCAMKL1 cells deep in the
intestinalized mucosa. The arrangement of DCAMKL1
cells and proliferating cells in the intestinalized mucosa
mimics that in the small intestinal crypt. These findings
indicate that DCAMKL1 is a common progenitor cell
marker in the gastrointestinal tract. It will be of interest
to determine how gastric stem cells become repro-
grammed to enter a differentiation program characteris-
tic of the small intestine.
Alterations of cell lineages in dysplasia are illustrated in
Figure 11B. Cystic dilation of glands was elicited and the
Figure 9 Sequential changes in cellular loss and recovery of the gastric gland after superficial mucosal injury with ethanol.
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Figure 10 Alterations of mucosal cell lineages in the margin of active and healing ulcers.
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Page 13 of 14morphological appearance was consistent with gastritis
cystic profunda as a precursor to dysplasia and neoplasia,
which develops in Helicobacter-infected animals and
humans[23,31]. The cystic regions invaded the submu-
cosa and were accompanied by SPEM, which also
expanded to the submucosa from the base of the mucosa.
It is of note that several studies have suggested that SPEM
is a precursor of gastric cancer[23,27,32]. DCAMKL1 and
TFF2 were expressed in dilated glands in this study.
Expression of DCAMKL1 has been reported in mouse
adenoma[9] and human colorectal cancer[12], and thus
DCAMKL1 and TFF2 are putative markers for gastric
carcinogenesis. A recent report showed that DCAMKL1
is a positive regulator of tumorigenesis in the colon[12],
but the function of DCAMKL1 in the gastrointestinal
tract is largely unknown.
Conclusions
The ultrastructural appearance of DCAMKL1 cells and
the expression patterns of DCAMKL1 in normal and
pathological states indicate that the cells belong to a pro-
genitor cell population. DCAMKL1 shows different
expression profiles in ulcer healing, intestinal metaplasia
and dysplasia, while DCAMKL1 expression is closely
associated with TFF2/SPEM cells.
DCAMKL1 is expressed close to proliferating, hyper-
plastic, metaplastic and dysplastic cells, and the progeni-
tor zone shifts according to the pathological
circumstances.
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